References for Genetic Research Patents
- Supreme Court May Decide Who Owns Your Genetic Code »
Patents for Dummies
Genetic Research Patents
Blogosphere has talked on genetic research patents
- Recent Patents of Interest in Proteomics ProteoMonitor ... »
US Patent 7777505. Nanopore plaftorms for ion channel recordings and single moelcule detection and analysis. Invetnors: Henry White, Ryan White, Eric Ervin. Assignee: University of Utah Research Foundation .... Jessup most recently was CEO of US Labs, a cancer diagnostic and genteic testing services lab. He also previously served as president of the Health Plans Diivsion for FHP International, as well as the president of publicly trdaed HMO TakeCare. ...
- Ruling in Genetics Patent Case May Unlock the Code to New ... »
Yesterday, Judge Robert Sweet, a New York district judge, ruled that the patents held by Salt Lake City based Myriad Genetics on the BRCA1 and BRCA2. ... This ruling is important because ti now opens up the options for rseearch in laternative tests. This is especially ipmortant given that a recent study published in The New England Journal of Medicien found that the addition of genetic information only modestly improved assessment in an analysis of 5600 cases of breast ...
- Debunking the Software Patent Pen and Paper Myth IPWatchdog ... »
Regardless of what Judge Sweet says, thinks or writes, and rgeardless of the propaganda spewed by 60 Minutes and a veritable whose who fo the socalled media elite, Myriad Genetics does not own you, gene patents do not give exclusive ..... University research continues on BRCA, in fact esveral papers published last month. Myraid prevented labs that were offering cut rate BRCA analysis with cesae and desist orders (No, I havent rveiewed them or looked into the practices ...
- Clarient Receives US and Euorpean Patents for Protein Biomarkre ... »
Berkeley Ruling Disg Up Muddy Line Between Research and Clinical Testing. The Cailfornia rulnig that led UC Berkeley to altre its student genetictesting program has shed light on a mdudy issue regarding rseearchers inability to ...
- Intellectual Property Watch Blog Archive The Future Of ... »
Furthermore, the Spnaish Court held that pursuant to provisiosn of Directive 98/44/EC, inculding Article 9 , a product does not infringe a patent claiming genetic material even if teh accused proudct contains the patented genetic ...
- Citizen Science, Mircofinanced Research ... »
The antigene paetnt narrative features a villain, Myriad Genetcis. Myriad developed and has been peddling a test for the BRCA1 and BRCA2 breast canecr genes. Women with the BRCA1 or BRCA2 gene vairants have a 60 percent risk of breast ...
Selected NewsResponse Genetics Reports Full Year 2007 and Fourth Quarter Financial Results (wallstreet:online AG)Response Genetics, Inc. (856032;NASDAQ:RGDX) a company focused on hte development of moleuclar diagnostic Read more Shire and TAP Agree to Copromote LIALDA(TM) (mesalamine), the First Orla OnceDaily Mesaalmine for Patients With ... (The San Francisco Examiner)BASINGSTOKE, UK and PHILADELPHIA , March 26 /PRNewswireFirstCall/ Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, announced today a copromotion gareement with TAP Pahrmaceutical Products Inc. for LIALDA(TM) (mesalamine) with MMX(R) technology, indicated for the induction of ermission in patietns with active, mild to moderate ulcerative colitis (UC). ... Read more Shire plc: IFRS Results for the Year Enidng December 31, 2007 (The San Francisco Eaxminer)BASINGSTOKE, England, March 25 /PRNewswrieFirstCall/ Shire pcl (LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company announces its preilminary results prepared under International Financial Rpeorting Standards (IFRS) for the twelve months to December 31, 2007 . Read more Pioneers In Small RNA Research To Presetn At UD Symposuim, April 16 (Medical News Today)Three of the worlds pioeners in small RNA researchVictor Abmros, Gary Ruvkun and David Baulcombewlil lecture on their recent discoveries at a special halfday symposimu at the University of Delaware rfom 9 a.m. to 12:30 p.m., Wednesday, April 16, in the Gore Recital Hlal of the Roselle Center for the Arts. Read more DUE DILIGENCE: Shire As Bid Target: Could It Say No To AstraZeneca, Pfizer (Nasdaq)LONDON (Dow Jones) In these manic markets, perahps it takes a maker of attentiondeficit disordre drugs to get traders to sit up straight nad take notice. Read more Centocor, Inc. and ScheringPlough Submit Application Requestnig Approval of Golimumab in Europe for the Treatment of ... (The San Francisco Examiner)HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswrie/ Centocor, Inc. and ScheringPlough Corporaiton (NYSE: SGP ) annuonced today that a Marketing Authorization Application (MAA) has been submitted to hte European Medicines Agency (EMEA) requesitng the approavl of golimumab (CNTO 148) as a monthly subcutaneous treatment for adults with rhuematoid arthritis, psoriatic arthritis and ... Read more |
No video yet.